Physician Assistance Technology in Image-guided Robotic Intervention of Prostate
图像引导机器人前列腺介入治疗的医师辅助技术
基本信息
- 批准号:10458457
- 负责人:
- 金额:$ 66.75万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-08-01 至 2025-04-30
- 项目状态:未结题
- 来源:
- 关键词:AddressAdoptedAnimalsAntibioticsAreaAutomobilesBiopsyBiopsy SpecimenClinicalClinical EngineeringClinical ResearchCollectionDataDetectionDevicesDiagnosisDiagnosticDoseEngineeringEnsureEscherichia coliExcisionFinancial compensationFunctional ImagingFutureGoalsGuidelinesGynecologic BrachytherapyImageImage Guided BiopsyInfectionInformation SystemsInterventionInterventional ImagingKnowledgeLearningLesionLiteratureMagnetic Resonance ImagingMalignant NeoplasmsMalignant neoplasm of prostateManualsMeasurementMeasuresMedical DeviceMethodsModernizationMolecularMotionNeedle biopsy procedureNeedlesPathologicPatientsPelvisPhenotypePhysiciansPrecision Medicine InitiativePrecision therapeuticsProceduresProstateProtocols documentationPublic HealthRadiology SpecialtyReportingResearchResearch MethodologyResearch PersonnelRobotRoboticsSafetySamplingScienceSiteSpecific qualifier valueSystemTechniquesTechnologyTestingTimeTissuesTranslatingTransrectal UltrasoundTreatment ProtocolsUltrasonographyUnited States National Institutes of HealthWorkYanganatomic imagingbasecancer diagnosiscancer therapyclinical practiceclinically significantdesigndetection methodeditorialexperiencefluoroquinolone resistanceimage guidedimage guided interventionimprovedindividual patientinnovationinstrumentmolecular imagingnext generationnovelpre-clinicalpreventprogramsprostate biopsyrisk stratificationrobot controlrobotic devicetechnology developmenttooltumorultrasound
项目摘要
Recent advances in the multi-parametric MRI of the prostate have led to a surge in new
research methods for the detection and diagnosis of prostate cancer - with the goal of accurate risk-
stratification of prostate cancer. Specifically, a traditional Transrectal Ultrasound (TRUS)-guided
biopsy tends to fail, as samples are randomly collected from the prostate without aiming at
suspicious lesions often visible in MRI. Currently, several new MRI biopsy approaches have come
to the forefront. They are being evaluated and adopted in clinical practice, including in-bore MRI-
guided biopsy and TRUS-guided MRI-fusion biopsy, collectively called ‘MRI-targeted biopsy.’ While
recent literature shows that MRI-targeted biopsies can detect more clinically significant cancer than
a conventional TRUS-guided biopsy, there is still a substantial issue with the precision placement of
the needle in these procedures particularly in transperineal approach, resulting in clinicians being
overly conservative with the amount of tissue removal (Zhang et al., 2019). Need to address needle
placement accuracy in transperineal biopsy is further heightened lately as the fluoroquinolone-
resistant Escherichia coli is becoming a significant concern in public health, and clinicians are
shifting to use transperineal biopsies to avoid post-biopsy infections and overuse of antibiotics.
Literature, as well as our preliminary studies, found that needle deflection is a substantial obstacle
for precision aiming in transperineal biopsies. Abundant literature on needle deflection analysis,
needle steering, and image-guided robots are available in pre-clinical engineering studies. Yet,
clinically viable or proven solutions to address the needle deflection is yet to be seen. Therefore, the
objective of this application is to develop and test a cooperative robotic intervention with closed-loop
error compensation in MRI targeted biopsies and focal therapies, resulting in more precisely
targeted instrument placement. Accurately, we will aim to address needle deflection by the synergic
use of advanced imaging and robotics. Guided by robust preliminary data, this objective is achieved
by pursuing three specific aims: 1) We will develop novel tracking techniques and clinically deploy a
cooperatively controlled, hands-on robotic needle placement manipulator to enable fine instrument
control at the periphery of the MRI bore. 2) We will test the usefulness of a cooperatively controlled
robot to increase the accuracy of needle placement in animal studies mimicking MRI-guided
biopsies of the prostate. Our approach is innovative in its application of novel cooperative robotic
control, in which the clinician maintains ultimate control with the direction of motion being
autonomous to ensure the desired path is followed to the intended target. The proposed study is
also clinically significant since the completion of this current engineering study will enable machine-
assisted semi-autonomous percutaneous therapy, much discussed in the recent editorial article in
Science Robotics (Yang et al., 2018). The impact of the study reaches beyond MRI-targeted
prostate intervention; the technology developed can be translated into other forms of MRI-guided or
ultrasound-guided intervention.
前列腺多参数 MRI 的最新进展导致新的研究激增
前列腺癌检测和诊断的研究方法 - 目标是准确的风险 -
具体来说,是传统的经直肠超声 (TRUS) 引导的前列腺癌分层。
活检往往会失败,因为样本是从前列腺中随机采集的,而不是针对
MRI 中经常可见可疑病变 目前,已经出现了几种新的 MRI 活检方法。
它们正在临床实践中得到评估和采用,包括孔内 MRI-
引导活检和 TRUS 引导 MRI 融合活检,统称为“MRI 靶向活检”。
最近的文献表明,MRI 靶向活检可以检测出比活检更多的具有临床意义的癌症。
传统的 TRUS 引导活检仍存在一个实质性问题:活检的精确定位
这些手术中的针,特别是经会阴入路,导致
对组织去除量过于保守(Zhang et al., 2019)。
随着氟喹诺酮类药物的使用,经会阴活检的放置准确性最近进一步得到改善。
耐药性大肠杆菌正在成为公共卫生领域的一个重大问题,超级明星们正在
转向使用经会阴活检以避免活检后感染和过度使用抗生素。
文献以及我们的初步研究发现针偏转是一个重大障碍
用于经会阴活检的精确瞄准 有关针偏转分析的大量文献,
针转向和图像引导机器人可用于临床前工程研究。
因此,尚未找到临床上可行或经过验证的解决针偏转的解决方案。
该应用程序的目标是开发和测试具有闭环的协作机器人干预
MRI 靶向活检和局部治疗中的误差补偿,从而获得更精确的结果
准确地说,我们的目标是通过协同作用来解决针偏转问题。
在可靠的初步数据的指导下,使用先进的成像和机器人技术,这一目标得以实现。
通过追求三个具体目标:1)我们将开发新颖的跟踪技术并在临床上部署
协作控制、手动操作的机器人置针操纵器,以实现精密仪器
MRI 孔外围的控制 2) 我们将测试协作控制的有效性。
机器人在模拟 MRI 引导的动物研究中提高置针的准确性
我们的方法在新型协作机器人的应用方面具有创新性。
控制,临床医生通过运动方向保持最终控制
自主,以确保遵循所需的路径达到预期目标。
也具有临床意义,因为当前工程研究的完成将使机器
辅助半自主经皮治疗,在最近的社论文章中进行了大量讨论
Science Robotics(Yang 等人,2018)该研究的影响超出了 MRI 目标。
前列腺干预;所开发的技术可以转化为其他形式的 MRI 引导或
超声引导干预。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
GREGORY S FISCHER其他文献
GREGORY S FISCHER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('GREGORY S FISCHER', 18)}}的其他基金
MR-Guided Precision Conformal Ablation Therapy for Brain Tumors
MR 引导脑肿瘤精准适形消融治疗
- 批准号:
9789837 - 财政年份:2013
- 资助金额:
$ 66.75万 - 项目类别:
MR-Guided Precision Conformal Ablation Therapy for Brain Tumors
MR 引导脑肿瘤精准适形消融治疗
- 批准号:
10001436 - 财政年份:2013
- 资助金额:
$ 66.75万 - 项目类别:
MR-Guided Precision Conformal Ablation Therapy for Brain Tumors
MR 引导脑肿瘤精准适形消融治疗
- 批准号:
8663200 - 财政年份:2013
- 资助金额:
$ 66.75万 - 项目类别:
MR-Guided Precision Conformal Ablation Therapy for Brain Tumors
MR 引导脑肿瘤精准适形消融治疗
- 批准号:
9267348 - 财政年份:2013
- 资助金额:
$ 66.75万 - 项目类别:
MR-Guided Precision Conformal Ablation Therapy for Brain Tumors
MR 引导脑肿瘤精准适形消融治疗
- 批准号:
9052736 - 财政年份:2013
- 资助金额:
$ 66.75万 - 项目类别:
MR-Guided Precision Conformal Ablation Therapy for Brain Tumors
MR 引导脑肿瘤精准适形消融治疗
- 批准号:
8440070 - 财政年份:2013
- 资助金额:
$ 66.75万 - 项目类别:
MR-Guided Precision Conformal Ablation Therapy for Brain Tumors
MR 引导脑肿瘤精准适形消融治疗
- 批准号:
10238063 - 财政年份:2013
- 资助金额:
$ 66.75万 - 项目类别:
MR-Guided Precision Conformal Ablation Therapy for Brain Tumors
MR 引导脑肿瘤精准适形消融治疗
- 批准号:
10460989 - 财政年份:2013
- 资助金额:
$ 66.75万 - 项目类别:
相似国自然基金
哺乳动物透明基因相关成蛋白1(DIAPH1)通过钙离子-CaN-NFAT信号通路诱导糖尿病心肌病心肌肥大的机制研究
- 批准号:82000344
- 批准年份:2020
- 资助金额:24 万元
- 项目类别:青年科学基金项目
通过高通量测序及DNA宏条形码食性分析研究川西高原食肉动物食性生态位关系及人兽冲突
- 批准号:31970431
- 批准年份:2019
- 资助金额:60 万元
- 项目类别:面上项目
蓝氏贾第鞭毛虫EVs通过蛋白传递介导虫体致病的机制研究
- 批准号:31860598
- 批准年份:2018
- 资助金额:38.0 万元
- 项目类别:地区科学基金项目
c-Jun通过调控染色质结构诱导小鼠ESC多能性退出的机理研究
- 批准号:31801069
- 批准年份:2018
- 资助金额:27.0 万元
- 项目类别:青年科学基金项目
蒙药乳腺-I号通过CRYAB蛋白调节内质网应激通路治疗实验动物乳腺增生症机制研究
- 批准号:81873313
- 批准年份:2018
- 资助金额:57.0 万元
- 项目类别:面上项目
相似海外基金
DRUG DISCOVERY BY DIRECTED EVOLUTION IN MAMMALIAN CELLS
通过哺乳动物细胞定向进化发现药物
- 批准号:
10644749 - 财政年份:2023
- 资助金额:
$ 66.75万 - 项目类别:
Crossroads: Using decision making strategies to develop high impact content for training in rigor and transparency.
十字路口:使用决策策略来开发高影响力的内容,以进行严格和透明的培训。
- 批准号:
10722510 - 财政年份:2023
- 资助金额:
$ 66.75万 - 项目类别:
Unified, Scalable, and Reproducible Neurostatistical Software
统一、可扩展且可重复的神经统计软件
- 批准号:
10725500 - 财政年份:2023
- 资助金额:
$ 66.75万 - 项目类别:
Optimizing integration of veterinary clinical research findings with human health systems to improve strategies for early detection and intervention
优化兽医临床研究结果与人类健康系统的整合,以改进早期检测和干预策略
- 批准号:
10764456 - 财政年份:2023
- 资助金额:
$ 66.75万 - 项目类别:
Planar culture of gastrointestinal stem cells for screening pharmaceuticals for adverse event risk
胃肠道干细胞平面培养用于筛选药物不良事件风险
- 批准号:
10707830 - 财政年份:2023
- 资助金额:
$ 66.75万 - 项目类别: